➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021887

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 021887 describes ALLI, which is a drug marketed by Glaxosmithkline Cons and is included in one NDA. Additional details are available on the ALLI profile page.

The generic ingredient in ALLI is orlistat. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the orlistat profile page.
Summary for 021887
Applicant:Glaxosmithkline Cons
Formulation / Manufacturing:see details
Paragraph IV (Patent) Challenges for 021887
Tradename Dosage Ingredient NDA Submissiondate
ALLI CAPSULE;ORAL orlistat 021887 2010-09-08

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CAPSULE;ORALStrength60MG
Approval Date:Feb 7, 2007TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.